All Stories

  1. Fatal and non-fatal events within 14 days after early, intensive mobilization post stroke
  2. A longitudinal examination of the frequency and correlates of self-reported neurobehavioural disability following stroke
  3. Patterns of use and discontinuation of secondary prevention medications after stroke
  4. Sex differences in quality of life after stroke were explained by patient factors, not clinical care: evidence from the Australian Stroke Clinical Registry
  5. Hospital Presentations in Long-Term Survivors of Stroke
  6. Stroke incidence and subtypes in Aboriginal people in remote Australia: a healthcare network population-based study
  7. Hospital admissions prior to primary intracerebral haemorrhage and relevant factors associated with survival
  8. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: An exploratory analysis using linked registry data
  9. Sex differences in aneurysmal subarachnoid haemorrhage (aSAH): aneurysm characteristics, neurological complications, and outcome
  10. Continuum of care approach for managing non-communicable diseases in low- and middle-income countries
  11. Hypertension in Rural India: The Contribution of Socioeconomic Position
  12. Incidence and risk factors for stroke following percutaneous coronary intervention
  13. Global Stroke Statistics 2019
  14. Factors Associated With 90-Day Readmission After Stroke or Transient Ischemic Attack
  15. Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial
  16. Disparities in Antihypertensive Prescribing After Stroke
  17. Sex differences in risk factors for aneurysmal subarachnoid haemorrhage: Systematic review and meta-analysis
  18. Measuring stroke and transient ischemic attack burden in New Zealand: Protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V)
  19. Blood Pressure, Aortic Stiffness, Hemodynamics, and Cognition in Twin Pairs Discordant for Type 2 Diabetes
  20. Sex Differences in Long-Term Quality of Life Among Survivors After Stroke in the INSTRUCT
  21. Protocol for evaluation of enhanced models of primary care in the management of stroke and other chronic disease (PRECISE)
  22. Early mobilization and quality of life after stroke
  23. Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries
  24. Prevalence of diabetes and pre-diabetes in rural Tehri Garhwal, India: influence of diagnostic method
  25. Factors that confound the prediction of renal medullary oxygenation and risk of acute kidney injury from measurement of bladder urine oxygen tension
  26. Multicenter, Prospective, Controlled, Before-and-After, Quality Improvement Study (Stroke123) of Acute Stroke Care
  27. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  28. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  29. Promising Use of Big Data to Increase the Efficiency and Comprehensiveness of Stroke Outcomes Research
  30. Sex Differences in Care and Long-Term Mortality After Stroke: Australian Stroke Clinical Registry
  31. The role of context in implementation research for non-communicable diseases: Answering the ‘how-to’ dilemma
  32. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol
  33. Evaluating recruitment strategies for AUSPICE , a large Australian community‐based randomised controlled trial
  34. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  35. Outcomes for Patients With In-Hospital Stroke: A Multicenter Study From the Australian Stroke Clinical Registry (AuSCR)
  36. Knowledge of risk factors for hypertension in a rural Indian population
  37. Stroke Severity Versus Dysphagia Screen as Driver for Post-stroke Pneumonia
  38. Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta‐Analysis of Individual Participant Data
  39. Large expert-curated database for benchmarking document
  40. A Promising Skills-Based Intervention to Reduce Blood Pressure in Individuals With Stroke and Transient Ischemic Attack
  41. Socioeconomic Status and Long-Term Stroke Mortality, Recurrence and Disability in Iran: The Mashhad Stroke Incidence Study
  42. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
  43. Maximising data value and avoiding data waste: a validation study in stroke research
  44. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  45. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  46. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  47. Department of Error
  48. Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases
  49. Prevention of stroke: a global perspective
  50. Neurobehavioral disability in stroke patients during subacute inpatient rehabilitation: prevalence and biopsychosocial associations
  51. Understanding the potential for yoga and tai chi interventions to moderate risk factors for stroke – a scoping review
  52. Early Mobilization After Stroke Is Not Associated With Cognitive Outcome
  53. Long-term disability after stroke in Iran: Evidence from the Mashhad Stroke Incidence Study
  54. Factors influencing self-reported anxiety or depression following stroke or TIA using linked registry and hospital data
  55. Development of an electronic health message system to support recovery after stroke: Inspiring Virtual Enabled Resources following Vascular Events (iVERVE)
  56. Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study
  57. Excess stroke incidence in young Aboriginal people in South Australia: Pooled results from two population-based studies
  58. Evaluation of a training program of hypertension for accredited social health activists (ASHA) in rural India
  59. Advances in Stroke 2017
  60. Factors contributing to sex differences in functional outcomes and participation after stroke
  61. Five-Year Case Fatality Following First-Ever Stroke in the Mashhad Stroke Incidence Study: A Population-Based Study of Stroke in the Middle East
  62. Preventing stroke on the street where you live, work, and play
  63. Urinary hypoxia: an intraoperative marker of risk of cardiac surgery-associated acute kidney injury
  64. The Incidence and Characteristics of Stroke in Urban-Dwelling Iranian Women
  65. Quality of Life Is Poorer for Patients With Stroke Who Require an Interpreter
  66. Prescription of antihypertensive medication at discharge influences survival following stroke
  67. Five-Year Recurrence Rate and the Predictors Following Stroke in the Mashhad Stroke Incidence Study: A Population-Based Cohort Study of Stroke in the Middle East
  68. Self-Reported Exercise Prevalence and Determinants in the Long Term After Stroke: The North East Melbourne Stroke Incidence Study
  69. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  70. Department of Error
  71. Improving quality and outcomes of stroke care in hospitals: Protocol and statistical analysis plan for the Stroke123 implementation study
  72. Global stroke statistics: An update of mortality data from countries using a broad code of “cerebrovascular diseases”
  73. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  74. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  75. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  76. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  77. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  78. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  79. Department of Error
  80. Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke
  81. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial
  82. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
  83. Long-term unmet needs and associated factors in stroke or TIA survivors
  84. Effectiveness of a shared team approach between nurses and doctors for improved risk factor management in survivors of stroke: a cluster randomized controlled trial
  85. Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR)
  86. The potential health and economic impact of improving stroke care standards for Australia
  87. Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program
  88. Effectiveness of an Intervention to Improve Risk Factor Knowledge in Patients With Stroke
  89. Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries
  90. Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy)
  91. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
  92. Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population
  93. Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East
  94. Global stroke epidemiology
  95. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
  96. Epidemiology of Intracranial and Extracranial Large Artery Stenosis in a Population-Based Study of Stroke in the Middle East
  97. Long-Term Outcomes of Ischemic Stroke of Undetermined Mechanism: A Population-Based Prospective Cohort
  98. Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review
  99. Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries
  100. Nurse-Led Intervention to Improve Knowledge of Medications in Survivors of Stroke or Transient Ischemic Attack: A Cluster Randomized Controlled Trial
  101. Neighborhood socioeconomic index and stroke incidence in a national cohort of blacks and whites
  102. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  103. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  104. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  105. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  106. Cluster randomised feasibility trial to improve the Control of Hypertension In Rural India (CHIRI): a study protocol
  107. Addressing the challenges of cross-jurisdictional data linkage between a national clinical quality registry and government-held health data
  108. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  109. Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)
  110. Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study
  111. The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries
  112. Case-fatality and functional status three months after first-ever stroke in Vietnam
  113. Better outcomes for hospitalized patients with TIA when in stroke units
  114. The Global Burden of Anemia
  115. Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
  116. AVERT 2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
  117. Personalized medicine and stroke prevention: where are we?
  118. 10.1016/S0140-6736(15)60692-4
  119. Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme
  120. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  121. Obesity Paradox versus Frailty Syndrome in First-Ever Ischemic Stroke Survivors
  122. A Risk Score to Predict Hypertension in Primary Care Settings in Rural India
  123. One-year case fatality rate following stroke in the Mashhad Stroke Incidence Study: a population-based study of stroke in Iran
  124. Authors’ Response to: Data sources for measuring the socioeconomic gradient of hypertension in rural populations of low- and middle-income countries
  125. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  126. Exploring threats to generalisability in a large international rehabilitation trial (AVERT)
  127. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
  128. Longitudinal Relationships Between Cognitive Decline and Gait Slowing: The Tasmanian Study of Cognition and Gait
  129. New Strategy to Reduce the Global Burden of Stroke
  130. Statistical analysis plan (SAP) for Shared Team Approach between Nurses and Doctors For Improved Risk Factor Management (STANDFIRM): a randomised controlled trial
  131. Methodology of the Stroke Self-Management Rehabilitation Trial: An International, Multisite Pilot Trial
  132. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  133. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
  134. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study
  135. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013
  136. Statistical Analysis Plan (SAP) for a Very Early Rehabilitation Trial (AVERT): An International Trial to Determine the Efficacy and Safety of Commencing out of Bed Standing and Walking Training (Very Early Mobilization) within 24 h of Stroke Onset vs. ...
  137. The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
  138. Trends Over Time in the Risk of Stroke After an Incident Transient Ischemic Attack
  139. Long-Term Costs of Stroke Using 10-Year Longitudinal Data From the North East Melbourne Stroke Incidence Study
  140. Progression of White Matter Hyperintensities of Presumed Vascular Origin Increases the Risk of Falls in Older People
  141. Rejoinder: Socioeconomic gradients and hypertension in low- and middle-income countries: a straw man and no solutions
  142. Expanding antiplatelet use for patients with stroke: The case for stroke of unknown type
  143. Geomagnetic Storms Can Trigger Stroke
  144. Do the socioeconomic and hypertension gradients in rural populations of low- and middle-income countries differ by geographical region? A systematic review and meta-analysis
  145. Adiposity has a greater impact on hypertension in lean than not-lean populations: a systematic review and meta-analysis
  146. Lower systolic blood pressure is associated with poorer survival in long-term survivors of stroke
  147. Advances in Stroke
  148. Discharge Is a Critical Time to Influence 10-Year Use of Secondary Prevention Therapies for Stroke
  149. Association between Farming and Chronic Energy Deficiency in Rural South India
  150. Estimating the annual number of strokes and the issue of imperfect data: an example from Australia
  151. Global stroke statistics
  152. Incidence of first ever stroke during Hajj ceremony
  153. Brain Structural Change and Gait Decline: A Longitudinal Population-Based Study
  154. What is Stroke Symptom Knowledge?
  155. Statin Therapy and Outcome After Ischemic Stroke
  156. The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
  157. Risk Factor Management in Survivors of Stroke: A Double-Blind, Cluster-Randomized, Controlled Trial
  158. A plea for the use of systematic review methodology when writing guidelines and timely publication of guidelines
  159. Baseline Smoking Status and the Long-Term Risk of Death or Nonfatal Vascular Event in People with Stroke
  160. Comparison of Stroke Warning Sign Campaigns in Australia, England, and Canada
  161. Vascular cognitive impairment and Alzheimer’s disease: role of cerebral hypoperfusion and oxidative stress
  162. Is Stroke Incidence in Low- to Middle-Income Countries Driven by Economics?
  163. Organized Blood Pressure Control Programs to Prevent Stroke in Australia
  164. Urinary symptoms and natural history of urinary continence after first-ever stroke—a longitudinal population-based study
  165. Advances in Health Policy and Outcome 2010–2011
  166. No Evidence for an Epidemic of Stroke with the Ageing of the Population
  167. Excess Risk of Stroke in Australia's Aboriginal and Torres Strait Islander Populations
  168. Factors associated with quality of life in 7-year survivors of stroke
  169. Gender-specific effects of caste and salt on hypertension in poverty: a population-based study
  170. Very Early Mobilization After Stroke Fast-Tracks Return to Walking: Further Results From the Phase II AVERT Randomized Controlled Trial
  171. How generalisable is INTERSTROKE?
  172. Protocol and Pilot Data for Establishing the Australian Stroke Clinical Registry
  173. Missed opportunities to prevent stroke recurrence
  174. Sex differences in presentation, severity, and management of stroke in a population-based study
  175. Potential roles of high salt intake and maternal malnutrition in the development of hypertension in disadvantaged populations
  176. The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)
  177. Systematic Review of Observational Studies
  178. Design and Methods of Population Surveys
  179. Case-Control Studies: The Importance of Design and Conduct
  180. Excessive Incidence of Stroke in Iran
  181. Stroke
  182. Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for Australia
  183. Very Early Mobilisation and Complications in the First 3 Months after Stroke: Further Results from Phase II of A Very Early Rehabilitation Trial (AVERT)
  184. Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women
  185. Smoking Cessation at 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  186. Teaching Courses
  187. Handicap 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  188. Individuals with first-ever clinical presentation of a lacunar infarction syndrome: Is there an increased likelihood of developing mild cognitive impairment in the first 12 months after stroke?
  189. Benefits and Challenges in Stroke Research in Developing Countries
  190. Patterns of Stroke Recurrence According to Subtype of First Stroke Event: The North East Melbourne Stroke Incidence Study (NEMESIS)
  191. Not All Stroke Units Are the Same: A Comparison of Physical Activity Patterns in Melbourne, Australia, and Trondheim, Norway
  192. Editorial
  193. A Very Early Rehabilitation Trial for Stroke (AVERT): Phase II Safety and Feasibility
  194. Estimating the Prevalence of Sleep-Disordered Breathing in Community-Based, Long-Term Stroke Survivors Using a Validated Predictive Model
  195. The effect of very early mobilisation after stroke on psychological well-being
  196. Economic Evaluation alongside a Phase II, Multi-Centre, Randomised Controlled Trial of Very Early Rehabilitation after Stroke (AVERT)
  197. Chapter 17 Stroke among women, ethnic groups, young adults, and children
  198. Risk Factors for Dementia
  199. Poverty and Stroke in India
  200. Why invest in a national public health program for stroke?
  201. The Large and Growing Burden of Stroke
  202. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
  203. Aboriginal and Torres Strait Islander Peoples and the Burden of Stroke
  204. Mobilisation ‘in Bed’ Is Not Mobilisation
  205. Vascular Cognitive Impairment
  206. Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study
  207. Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort
  208. A Very Early Rehabilitation Trial (AVERT)
  209. Control of Hypertension 5 Years After Stroke in the North East Melbourne Stroke Incidence Study
  210. Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas: The Northeast Melbourne Stroke Incidence Study
  211. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke
  212. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke
  213. Long-Term Outcome in the North East Melbourne Stroke Incidence Study
  214. HYPERTENSION 2020: CONFRONTING TOMORROW'S PROBLEM TODAY
  215. Cerebrovascular disease and dementia
  216. Knowledge of risk factors and warning signs of stroke
  217. Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit?
  218. Quality of Life After Stroke
  219. Progressive dementia after first-ever stroke: A community-based follow-up study
  220. Cholesterol Is Associated With Stroke, but Is Not a Risk Factor
  221. Trial Application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to Assist Priority Setting in Stroke
  222. Determinants of Handicap After Stroke
  223. Inactive and Alone: Physical Activity Within the First 14 Days of Acute Stroke Unit Care
  224. ‘Out of pocket’ costs to stroke patients during the first year after stroke – results from the North East Melbourne Stroke Incidence Study
  225. Smoking as a Crucial Independent Determinant of Stroke
  226. Lifetime Cost of Stroke Subtypes in Australia
  227. Editorial Comment—Minor Risk Factors for Intracerebral Hemorrhage: The Jury Is Still Out
  228. Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
  229. Increased Risk of Cognitive Impairment 3 Months After Mild to Moderate First-Ever Stroke
  230. The role of blood pressure lowering before and after stroke
  231. Incidence and Outcome of Subtypes of Ischaemic Stroke: Initial Results from the North East Melbourne Stroke Incidence Study (NEMESIS)
  232. Brief Comprehensive Quality of Life Assessment After Stroke
  233. RE: "DOES TEA AFFECT CARDIOVASCULAR DISEASE? A META-ANALYSIS"
  234. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage
  235. Informal Care for Stroke Survivors
  236. Handicap After Stroke: How Does It Relate to Disability, Perception of Recovery, and Stroke Subtype?
  237. Reduced Risk of Intracerebral Hemorrhage With Dynamic Recreational Exercise but Not With Heavy Work Activity
  238. Incidence of the Major Stroke Subtypes
  239. Inter-rater reliability of stroke sub-type classification by neurologists and nurses within a community-based stroke incidence study
  240. Hypertension and the risk of intracerebral haemorrhage: special considerations in patients with renal disease
  241. Heavy Drinking, but Not Moderate or Intermediate Drinking, Increases the Risk of Intracerebral Hemorrhage
  242. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group.
  243. Interrater Reliability of the National Institutes of Health Stroke Scale: Rating by Neurologistsand N urses in a Community-Based Stroke Incidence Study
  244. The Risk of Intracerebral Haemorrhage with Smoking
  245. Acute Brain Infarction: Early Changes in Neurological Status
  246. Risk Factors for Cerebral Hemorrhage in the Era of Well-Controlled Hypertension
  247. Epidemiology of Intracerebral Hemorrhage
  248. Hypertension as a Risk Factor for Stroke Subtypes
  249. Smoking as a Risk Factor for Stroke